Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.7%

1 terminated out of 13 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results80% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (8)
Early P 1 (1)
P 2 (1)
P 4 (1)

Trial Status

Completed4
Not Yet Recruiting2
Unknown2
Recruiting2
Suspended1
Terminated1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (13)

Research Network

Activity Timeline